287 related articles for article (PubMed ID: 17848512)
1. Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1.
Ramsland PA; Willoughby N; Trist HM; Farrugia W; Hogarth PM; Fraser JD; Wines BD
Proc Natl Acad Sci U S A; 2007 Sep; 104(38):15051-6. PubMed ID: 17848512
[TBL] [Abstract][Full Text] [Related]
2. A competitive mechanism for staphylococcal toxin SSL7 inhibiting the leukocyte IgA receptor, Fc alphaRI, is revealed by SSL7 binding at the C alpha2/C alpha3 interface of IgA.
Wines BD; Willoughby N; Fraser JD; Hogarth PM
J Biol Chem; 2006 Jan; 281(3):1389-93. PubMed ID: 16293625
[TBL] [Abstract][Full Text] [Related]
3. The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc alpha RI binding and serum killing of bacteria.
Langley R; Wines B; Willoughby N; Basu I; Proft T; Fraser JD
J Immunol; 2005 Mar; 174(5):2926-33. PubMed ID: 15728504
[TBL] [Abstract][Full Text] [Related]
4. Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc.
Herr AB; Ballister ER; Bjorkman PJ
Nature; 2003 Jun; 423(6940):614-20. PubMed ID: 12768205
[TBL] [Abstract][Full Text] [Related]
5. Full functional activity of SSL7 requires binding of both complement C5 and IgA.
Lorenz N; Clow F; Radcliff FJ; Fraser JD
Immunol Cell Biol; 2013 Aug; 91(7):469-76. PubMed ID: 23797068
[TBL] [Abstract][Full Text] [Related]
6. Episodes of natural selection shaped the interactions of IgA-Fc with FcalphaRI and bacterial decoy proteins.
Abi-Rached L; Dorighi K; Norman PJ; Yawata M; Parham P
J Immunol; 2007 Jun; 178(12):7943-54. PubMed ID: 17548632
[TBL] [Abstract][Full Text] [Related]
7. Interaction of human, rat, and mouse immunoglobulin A (IgA) with Staphylococcal superantigen-like 7 (SSL7) decoy protein and leukocyte IgA receptor.
Wines BD; Ramsland PA; Trist HM; Gardam S; Brink R; Fraser JD; Hogarth PM
J Biol Chem; 2011 Sep; 286(38):33118-24. PubMed ID: 21784854
[TBL] [Abstract][Full Text] [Related]
8. FcαRI binding at the IgA1 C
Posgai MT; Tonddast-Navaei S; Jayasinghe M; Ibrahim GM; Stan G; Herr AB
Proc Natl Acad Sci U S A; 2018 Sep; 115(38):E8882-E8891. PubMed ID: 30181292
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulins and their receptors, and subversion of their protective roles by bacterial pathogens.
Woof JM
Biochem Soc Trans; 2016 Dec; 44(6):1651-1658. PubMed ID: 27913674
[TBL] [Abstract][Full Text] [Related]
10. Localization of the binding site for the monocyte immunoglobulin (Ig) A-Fc receptor (CD89) to the domain boundary between Calpha2 and Calpha3 in human IgA1.
Carayannopoulos L; Hexham JM; Capra JD
J Exp Med; 1996 Apr; 183(4):1579-86. PubMed ID: 8666916
[TBL] [Abstract][Full Text] [Related]
11. Functional basis for complement evasion by staphylococcal superantigen-like 7.
Bestebroer J; Aerts PC; Rooijakkers SH; Pandey MK; Köhl J; van Strijp JA; de Haas CJ
Cell Microbiol; 2010 Oct; 12(10):1506-16. PubMed ID: 20545943
[TBL] [Abstract][Full Text] [Related]
12. Identification of Set11 from Staphylococcus aureus Mu50 strain as a ortholog of SSL7 via bioinformatic analysis and determination of its possible targets from human serum using CNBr-pull down assays.
Li Y; Chen X; Jia N; Zhang X; Zang J
Biotechnol Lett; 2017 Sep; 39(9):1413-1423. PubMed ID: 28653102
[TBL] [Abstract][Full Text] [Related]
13. Identification of residues in the CH2/CH3 domain interface of IgA essential for interaction with the human fcalpha receptor (FcalphaR) CD89.
Pleass RJ; Dunlop JI; Anderson CM; Woof JM
J Biol Chem; 1999 Aug; 274(33):23508-14. PubMed ID: 10438530
[TBL] [Abstract][Full Text] [Related]
14. IgA and the IgA Fc receptor.
van Egmond M; Damen CA; van Spriel AB; Vidarsson G; van Garderen E; van de Winkel JG
Trends Immunol; 2001 Apr; 22(4):205-11. PubMed ID: 11274926
[TBL] [Abstract][Full Text] [Related]
15. The crystal structure of staphylococcal superantigen-like protein 11 in complex with sialyl Lewis X reveals the mechanism for cell binding and immune inhibition.
Chung MC; Wines BD; Baker H; Langley RJ; Baker EN; Fraser JD
Mol Microbiol; 2007 Dec; 66(6):1342-55. PubMed ID: 18045383
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for inhibition of complement C5 by the SSL7 protein from Staphylococcus aureus.
Laursen NS; Gordon N; Hermans S; Lorenz N; Jackson N; Wines B; Spillner E; Christensen JB; Jensen M; Fredslund F; Bjerre M; Sottrup-Jensen L; Fraser JD; Andersen GR
Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3681-6. PubMed ID: 20133685
[TBL] [Abstract][Full Text] [Related]
17. Peptide mimetics of immunoglobulin A (IgA) and FcαRI block IgA-induced human neutrophil activation and migration.
Heineke MH; van der Steen LPE; Korthouwer RM; Hage JJ; Langedijk JPM; Benschop JJ; Bakema JE; Slootstra JW; van Egmond M
Eur J Immunol; 2017 Oct; 47(10):1835-1845. PubMed ID: 28736835
[TBL] [Abstract][Full Text] [Related]
18. The era of the immunoglobulin A Fc receptor FcαRI; its function and potential as target in disease.
Aleyd E; Heineke MH; van Egmond M
Immunol Rev; 2015 Nov; 268(1):123-38. PubMed ID: 26497517
[TBL] [Abstract][Full Text] [Related]
19. Structural relationships and cellular tropism of staphylococcal superantigen-like proteins.
Al-Shangiti AM; Naylor CE; Nair SP; Briggs DC; Henderson B; Chain BM
Infect Immun; 2004 Jul; 72(7):4261-70. PubMed ID: 15213171
[TBL] [Abstract][Full Text] [Related]
20. IgA Fc receptors.
Monteiro RC; Van De Winkel JG
Annu Rev Immunol; 2003; 21():177-204. PubMed ID: 12524384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
